Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at four penny stocks, Glatfelter Corporation (GLT), NetSol Technologies, Inc. (NTWK), Clearside Biomedical, Inc. (CLSD), and Lixte Biotechnology Holdings, Inc. (LIXT), have recently made significant purchases. This could indicate their confidence in the companies' prospects. Glatfelter has entered into a marketing agreement with Ekman & Co., while NetSol reported a YoY decrease in Q4 EPS results and issued FY24 revenue guidance. Clearside Biomedical posted a wider-than-expected Q2 loss, and Lixte recently appointed a new President and CEO.
October 05, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
10% owner Duane Clint Carlson acquired 325,000 shares of Glatfelter Corporation at an average price of $1.94. The company has also entered into a marketing agreement with Ekman & Co.
The insider purchase and the new marketing agreement could potentially boost the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Director Rene Bernards acquired 10,000 shares of Lixte Biotechnology at an average price of $2.41. The company recently appointed a new President and CEO.
The insider purchase and the appointment of a new President and CEO could potentially boost the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
CEO Najeeb Ghauri acquired 5,000 shares of NetSol Technologies at an average price of $1.90. The company reported a YoY decrease in Q4 EPS results and issued FY24 revenue guidance.
While the insider purchase indicates confidence, the decrease in Q4 EPS results could potentially offset any positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Director Nancy Hutson acquired 10,000 shares of Clearside Biomedical at an average price of $0.86. The company posted a wider-than-expected Q2 loss.
Despite the insider purchase, the wider-than-expected Q2 loss could negatively impact the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100